HEIDSTAR at the Single-Cell Sequencing Conference in Guangzhou, April 15, 2023

HEIDSTAR, a high-tech company focused on biomedical research and life sciences, will attend the single-cell sequencing conference in Guangzhou on April 15 at booth A09.

The conference will bring together experts and scholars in single-cell sequencing from China and abroad to discuss applications of single-cell technology in cancer, immunology, reproduction, neuroscience and other fields, and to share research results and technical progress. HEIDSTAR will present its latest single-cell sequencing technologies and products, including single-cell capture, single-cell sequencing and single-cell analysis, together with data analysis and interpretation software.

As a newcomer to single-cell sequencing, HEIDSTAR is committed to bringing cutting-edge technology to researchers and laboratories worldwide to advance science and medicine. The conference offers a platform for exchange and cooperation between academia and industry to jointly advance the development and application of single-cell sequencing technology.

HEIDSTAR looks forward to meeting attendees and exploring together the possibilities of single-cell sequencing in biomedical research and clinical applications.